Back to dashboard
Medicare AdvantageCoverageLow impact

MA11.049g, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids

Independence Blue Cross·ENT (Ear, Nose & Throat), Neurology·Medical Policy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Days to comply

Summary

A Medicare Advantage policy for bone-anchored hearing aids and implantable middle ear hearing aids has been reissued and will take effect on May 28, 2025. This is a policy update that may contain changes to coverage criteria, documentation requirements, or billing procedures for these specialized hearing devices.

Action Required

Action needed
By May 28, 2025: Billing team should review the complete updated policy MA11.049g for bone-anchored hearing aids and implantable middle ear hearing aids to identify any changes to coverage criteria, prior authorization requirements, or documentation standards. Access the full policy document from the source URL to determine specific billing impacts.